Eupraxia Pharmaceuticals Inc.: Form 40-F for the period ended Dec 31, 2025
Filed with the SEC on Mar 13, 2026 and accepted by EDGAR at Mar 12, 2026, 21:18 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $0 | us-gaap:Revenues |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $21.3m | us-gaap:ResearchAndDevelopmentExpense |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $0 | us-gaap:InterestExpense |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $19.1k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | −$38.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | −$1.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | −$1.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 39,956,133 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | −$28.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2025-12-31 | $80.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $85.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $86.2m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $5.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $5.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-12-31 | $82.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-26-104765. Last ingested by Listed: Nov 11, 2026, 03:36 ET. Listed shows no prices and gives no investment advice.